INHIBITORS OF AKT ACTIVITY

(19)

(11)

EP 1 898 903 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	15.05.2013 Bulletin 2013/20

(45)	Mention of the grant of the patent:
	27.03.2013 Bulletin 2013/13

(21)	Application number: 06772406.2

(22)	Date of filing: 07.06.2006

(51)

International Patent Classification (IPC):

A61K 31/41^(2006.01)

C07D 249/00^(2006.01)

(86)	International application number:
	PCT/US2006/022079

(87)	International publication number:
	WO 2006/135627 (21.12.2006 Gazette 2006/51)

(54)	INHIBITORS OF AKT ACTIVITY HEMMER VON AKT-AKTIVITÄT INHIBITEURS DE L'ACTIVITE AKT

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	HR

(30)

Priority:

10.06.2005 US 689726 P
07.11.2005 US 734188 P

(43)	Date of publication of application:
	19.03.2008 Bulletin 2008/12

(73)	Proprietor: Merck Sharp & Dohme Corp.
	Rahway, NJ 07065-0907 (US)

(72)

Inventors:

ARMSTRONG, Donna, J.
Rahway, New Jersey 07065-0907 (US)
HU, Essa, H.
Rahway, New Jersey 07065-0907 (US)
KELLY, Michael, J. III
Rahway, New Jersey 07065-0907 (US)
LAYTON, Mark, E.
Rahway, New Jersey 07065-0907 (US)
LI, Yiwei
Rahway, New Jersey 07065-0907 (US)
LIANG, Jun
Rahway, New Jersey 07065-0907 (US)
RODZINAK, Kevin, J.
Rahway, New Jersey 07065-0907 (US)
ROSSI, Michael, A.
Rahway, New Jersey 07065-0907 (US)
SANDERSON, Philip, E.
Rahway, New Jersey 07065-0907 (US)
WANG, Jiabing
Rahway, New Jersey 07065-0907 (US)

(74)	Representative: Hussain, Deeba et al
	Merck & Co., Inc. Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU Hoddesdon Hertfordshire EN11 9BU (GB)

(56)

References cited: :

WO-A1-00/56710
WO-A2-2004/096130
US-A1- 2003 199 511
US-B1- 6 407 108

WO-A2-2004/018419
US-A- 4 831 013
US-A1- 2003 199 511
US-B1- 6 613 766

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).